Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Samuel F Hunter, Jas Bindra, Ishveen Chopra, John Niewoehner, Mary P Panaccio & George J Wan. (2021) Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis. ClinicoEconomics and Outcomes Research 13, pages 883-892.
Read now
Read now
Hasssan Abolhassani, Mohammad Hossein Asgardoon, Nima Rezaei, Lennart Hammarstrom & Asghar Aghamohammadi. (2015) Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?. Expert Review of Clinical Immunology 11:11, pages 1229-1243.
Read now
Read now
James B Caress, Burton L Kennedy & Kara D Eickman. (2010) Safety of intravenous immunoglobulin treatment. Expert Opinion on Drug Safety 9:6, pages 971-979.
Read now
Read now
Yoav Arnson, Yehuda Shoenfeld & Howard Amital. (2009) Intravenous immunoglobulin therapy for autoimmune diseases. Autoimmunity 42:6, pages 553-560.
Read now
Read now
Articles from other publishers (19)
Buse Rahime Hasırcı Bayır, Miraç Ayşen Ünsal, Cansu Ağırcan, Tuba Cerrahoğlu Şirin, Onur Akan, Gizem Gürsoy, Tuğba Eyigürbüz, Dilara Mermi Dibek, Gönül Akdağ, Ayşe Deniz Elmalı, Ezgi Nazlı, Fatma Akkoyun Arıkan, Sezin Alpaydın Baslo, Dilek Ağırcan, Emel Oguz-Akarsu, Özdem Ertürk Çetin, Tülin Gesoğlu Demir, Esra Acıman Demirel, Doğa Vurallı, Şule Deveci, Tuba Tanyel, Füsun Mayda Domaç, Necdet Karlı, Sibel Velioğlu, Betül Baykan, Ayla Çulha Oktar, Ferda İlgen Uslu, Nevra Öksüz, Nazan Karagöz Sakallı, Belgin Munise Mutluay, Pınar Bekdik & Zeynep Vildan Okudan Atay. (2023) IVIg-induced headache: prospective study of a large cohort with neurological disorders. Neurological Sciences 44:8, pages 2871-2881.
Crossref
Crossref
Jonas Graf, Jens Ingwersen, Klaudia Lepka, Philipp Albrecht, Hans‐Peter Hartung, Marius Ringelstein & Orhan Aktas. (2019) Factors associated with headache in intravenous immunoglobulin treatment for neurological diseases. Acta Neurologica Scandinavica 140:4, pages 290-295.
Crossref
Crossref
Asaf Shemer, Shaye Kivity & Yehuda Shoenfeld. (2017) Clinical indications for intravenous immunoglobulin utilization in a tertiary medical center: a 9‐year retrospective study. Transfusion 58:2, pages 430-438.
Crossref
Crossref
Clare Baecher-Allan, Belinda J. Kaskow & Howard L. Weiner. (2018) Multiple Sclerosis: Mechanisms and Immunotherapy. Neuron 97:4, pages 742-768.
Crossref
Crossref
Shani Dahan, Yahel Segal, Abdulla Watad, Shir Azrielant, Asaf Shemer, Dror Maymon, Yuri I. Stroev, Polina A. Sobolevskaya, Elena A. Korneva, Miri Blank, Boris Gilburd, Ora Shovman, Howard Amital, Michael Ehrenfeld, Amir Tanay, Shay Kivity, Elon Pras, Joav Chapman, Jan Damoiseaux, Ricard Cervera, Chaim Putterman, Iziaslav Shapiro, Luc Mouthon, Roberto Perricone, Nicola Bizzaro, Omry Koren, Gabriela Riemekasten, Valeriy A. Chereshnev, Vadim I. Mazurov, Mark Goloviznin, Victor Gurevich, Leonid P. Churilov & Yehuda Shoenfeld. (2017) Novelties in the field of autoimmunity – 1st Saint Petersburg congress of autoimmunity, the bridge between east and west. Autoimmunity Reviews 16:12, pages 1175-1184.
Crossref
Crossref
Melinda Liu, Yuan Yu M. Huang, Sylvia Hsu & Joseph S. Kass. (2016) Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications. CNS Drugs 30:12, pages 1149-1168.
Crossref
Crossref
Ryuki Matsuura, Shin-ichiro Hamano, Yuko Hirata, Atsuko Oba, Kotoko Suzuki & Kenjiro Kikuchi. (2016) Intravenous immunoglobulin therapy is rarely effective as the initial treatment in West syndrome: A retrospective study of 70 patients. Journal of the Neurological Sciences 368, pages 140-144.
Crossref
Crossref
Patrick Cherin, Isabelle Marie, Mauricette Michallet, Eric Pelus, Jacques Dantal, Jean-Charles Crave, Jean-Christophe Delain & Jean-Fran?ois Viallard. (2016) Management of adverse events in the treatment of patients with immunoglobulin therapy: A review of evidence. Autoimmunity Reviews 15:1, pages 71-81.
Crossref
Crossref
G. N. Bisaga, I. D. Skulyabin & A. E. Popov. (2015) Intravenous immunoglobulins: perspectives in multiple sclerosis (a literature review with own results). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 115:8. Vyp. 2, pages 36.
Crossref
Crossref
Giovanni Ferrara, Alimuddin Zumla & Markus Maeurer. (2012) Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections. The American Journal of Medicine 125:10, pages 1036.e1-1036.e8.
Crossref
Crossref
Yehuda Shoenfeld. (2011) The Future of Autoimmunity. Clinical Reviews in Allergy & Immunology 42:2, pages 113-120.
Crossref
Crossref
Cris S Constantinescu, Nasr Farooqi, Kate O'Brien & Bruno Gran. (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). British Journal of Pharmacology 164:4, pages 1079-1106.
Crossref
Crossref
M. Jennifer Cheng & Colleen Christmas. (2011) Special Considerations with the Use of Intravenous Immunoglobulin in Older Persons. Drugs & Aging 28:9, pages 729-736.
Crossref
Crossref
Patrick Chérin & Jean Cabane. (2010) Relevant Criteria for Selecting an Intravenous Immunoglobulin Preparation for Clinical Use. BioDrugs 24:4, pages 211-223.
Crossref
Crossref
Beatrix KotlanDavid F Stroncek & Francesco M Marincola. (2009) Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science. Immunotherapy 1:6, pages 995-1015.
Crossref
Crossref
S. Schwarz, H.-M. Meinck & B. Storch-Hagenlocher. (2009) Intravenöse Immunglobuline bei Multipler SkleroseIntravenous immunoglobulins in multiple sclerosis. Der Nervenarzt 80:8, pages 918-928.
Crossref
Crossref
Mary Requena, Hicham Bouhlal, Nadine Nasreddine, Hela Saidi, Jean-Chrysostome Gody, Sylvie Aubry, Gérard Grésenguet, Michel D. Kazatchkine, Rafick-Pierre Sekaly, Laurent Bélec & Hakim Hocini. (2008)
Inhibition of HIV-1 transmission in trans from dendritic cells to CD4
+
T lymphocytes by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins
. Immunology 123:4, pages 508-518.
Crossref
Crossref
Hakan M Gürcan & A Razzaque Ahmed. (2016) Frequency of Adverse Events Associated with Intravenous Immunoglobulin Therapy in Patients with Pemphigus or Pemphigoid. Annals of Pharmacotherapy 41:10, pages 1604-1610.
Crossref
Crossref
Michele D Mignogna, Giulio Fortuna, Elvira Ruoppo, Daniela Adamo, Stefania Leuci & Stefano Fedele. (2007) Variations in Serum Hemoglobin, Albumin, and Electrolytes in Patients Receiving Intravenous Immunoglobulin Therapy. American Journal of Clinical Dermatology 8:5, pages 291-299.
Crossref
Crossref